期刊文献+

MELD评分联合氨基末端脑钠肽前体评估肝硬化门脉高压出血患者短期预后的价值 被引量:1

Predictive value of MELD score combined with serum N-terminal brain natriuretic pro-peptide on short-term prognosis of cirrhosis patients with portal hypertension-related bleeding
原文传递
导出
摘要 目的探讨MELD评分联合氨基末端脑钠肽前体(NT-Pro-BNP)预测肝硬化门脉高压食管胃静脉曲张出血患者出血后3个月预后的临床价值。方法选取2016年1月至2018年6月于杭州市西溪医院入住ICU的肝硬化食管胃曲张静脉出血患者97例,以3个月为观察期,分为生存组(78例)和死亡组(19例),比较两组患者出血后24 h时的血清总胆红素、肌酐、国际标准化比值、血清钠、MELD评分和NT-Pro-BNP。受试者工作特征曲线下面积(AUC)分析MELD评分联合NT-Pro-BNP的诊断价值。结果死亡组患者消化道出血后24h的总胆红素98.0(39.4,112.5)μmol/L高于生存组33.1(17.8,66.2)μmol/L,国际标准化比值1.9(1.4,2.0)高于生存组1.4(1.2,1.7),MELD评分17.0(16.8,22.0)高于生存组13.0(10.8,17.5),NT-Pro-BNP 770.0(454.0,3347.0)pg/mL高于生存组329.0(93.0,693.0)pg/mL,差异有统计学意义(Z=-2.782、-2.696、-3.591、-3.559,P<0.05)。MELD评分、NT-pro-BNP预测肝硬化食管胃静脉曲张破裂出血患者近期死亡危险性的最佳临界值分别为14.5和448.5 pg/mL。MELD评分联合NT-pro-BNP判断肝硬化食管胃静脉曲张出血患者短期预后的AUC为0.836,高于单独MELD评分的0.766和NT-pro-BNP的0.821。结论MELD评分联合NT-Pro-BNP对预测肝硬化食管胃静脉曲张出血患者短期预后的预测价值良好。 Objective To investigate the predictive value of combined model for MELD score and serum N-terminal brain natriuretic pro-peptide(NT-Pro-BNP)on the 3-month prognosis of cirrhosis patients with bleeding esophageal varices.Methods A total of 97 cirrhosis patients with bleeding esophageal varices from January 2016 to June 2018 in Xixi Hospital were respectively analyzed,and divided into survival group(78 cases)and death group(19 cases)according to the prognosis by 3-month follow-up.Serum TBil,creatinine(Cr),international normalized ratio(INR),Na,MELD score and serum NT-Pro-BNP were measured 24 h after bleeding and compared between the two groups.The capability of MELD score combined with serum NT-Pro-BNP was evaluated by area under curve(AUC).Results In death group,serum levels of TBil,INR,MELD score and NT-Pro-BNP were 98.0(39.4,112.5)μmol/L,1.9(1.4,2.0),17.0(16.8,22.0)and 770.0(454.0,3347.0)pg/mL,which were all higher than those in survival group of 33.1(17.8,66.2)μmol/L,1.4(1.2,1.7),13.0(10.8,17.5)and 329.0(93.0,693.0)pg/mL(Z=-2.782,-2.696,-3.591,-3.559,P<0.05).The optimal cut-off value of MELD score and serum level of NT-Pro-BNP in predicting short-term mortality of cirrhosis patients with bleeding esophageal varices were 14.5 and 448.5 pg/mL.The AUC of combined MELD score and NT-Pro-BNP was 0.836,which was higher than that of single MELD score(0.766)or NT-Pro-BNP(0.821),respectively.Conclusions MELD score combined with serum NT-Pro-BNP has a good predictive value for the short-term prognosis in cirrhosis patients with bleeding esophageal varices.
作者 周可幸 张思泉 刘华锋 韩加裕 赵曦 Zhou Kexing;Zhang Siquan;Liu Huafeng;Han Jiayu;Zhao Xi(Intensive Care Unit,Xixi Hospital,Hangzhou 310023,China;Medical Records Department,Xixi Hospital,Hangzhou 310023,China)
出处 《国际流行病学传染病学杂志》 CAS 2019年第6期505-508,共4页 International Journal of Epidemiology and Infectious Disease
基金 浙江省医药卫生科技计划(2019KY531)。
关键词 肝硬化 静脉曲张 MELD评分 氨基末端脑钠肽前体 预后 Liver cirrhosis Varicose veins Model for end-stage liver disease score NT-Pro-BNP Prognosis
  • 相关文献

参考文献2

二级参考文献24

  • 1李丽平.肝硬化非食管胃底静脉曲张破裂60例临床分析[J].职业与健康,2005,21(11):1838-1839. 被引量:1
  • 2李兆申,湛先保.食管胃静脉曲张出血的诊治建议(草案)[J].中华内科杂志,2006,45(6):524-526. 被引量:46
  • 3陆再英,钟南山.内科学.7版.北京:人民卫生出版社,2008,1:267-294. 被引量:275
  • 4Huo TI,Lin HC,Wu JC,et al.Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.Liver Transpl,2006,12:65-71. 被引量:1
  • 5Kamath PS,Wiesner RH,Malinchoc M,et al.A model to predict survival in patients with end-stage liver disease.Hepatology,2001,33:464-470. 被引量:1
  • 6Fong TV,Hung FC,Chiu KW,et al.Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients.Hepatogastroenterology,2008,55:1055-1058. 被引量:1
  • 7Heuman DM,Abou-Assi SG,Habib A,et al,Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.Hepatology,2004,40:802-810. 被引量:1
  • 8Angeli P,Wong F,Watson H,et al.Hyponatremia in cirrhosis:Results of a patient population survey.Hepatology,2006,44:1535-1542. 被引量:1
  • 9Biggins SW,Kim WR,Terrault NA,et al.Evidence-based incorporation of serum sodium concentration into MELD.Gastroenterology,2006,130:1652-1660. 被引量:1
  • 10Wiesner R,Edwards E,Freeman R,et al.Model for endstage liver disease (MELD) and allocation of donor livers.Gastroenterology,2003,124:91-96. 被引量:1

共引文献8

同被引文献17

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部